| scholarly article | Q13442814 |
| P50 | author | Thomas J. Hawke | Q45342869 |
| James A. Richardson | Q119723137 | ||
| Sean C. Goetsch | Q123857459 | ||
| P2093 | author name string | Daniel J Garry | |
| Cindy M Martin | |||
| Scott M Robertson | |||
| Susan Bates | |||
| Teresa D Gallardo | |||
| Annette P Meeson | |||
| P2860 | cites work | Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells | Q24672061 |
| Stem Cells | Q28111899 | ||
| The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors | Q28214940 | ||
| Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor | Q28510070 | ||
| Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C | Q28589290 | ||
| The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype | Q29615563 | ||
| "Stemness": transcriptional profiling of embryonic and adult stem cells | Q29618765 | ||
| Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo | Q29619355 | ||
| Heart regeneration in zebrafish | Q29619776 | ||
| From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. | Q30328533 | ||
| Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. | Q31847380 | ||
| Hematopoietic potential of stem cells isolated from murine skeletal muscle | Q33179264 | ||
| Stem cells: a new lease on life | Q33824741 | ||
| Heart regeneration in adult MRL mice | Q33933931 | ||
| Mammalian myotube dedifferentiation induced by newt regeneration extract | Q33949975 | ||
| Myogenic satellite cells: physiology to molecular biology | Q34084128 | ||
| A stem cell molecular signature | Q34149366 | ||
| Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo | Q34156054 | ||
| ABC transporters as phenotypic markers and functional regulators of stem cells | Q34498500 | ||
| Myocyte renewal and ventricular remodelling | Q34503420 | ||
| RNA amplification and transcriptional profiling for analysis of stem cell populations | Q40620589 | ||
| The post-natal heart contains a myocardial stem cell population. | Q45855585 | ||
| The heart LIM protein gene (Hlp), expressed in the developing and adult heart, defines a new tissue-specific LIM-only protein family | Q48292499 | ||
| Universal GFP reporter for the study of vascular development. | Q52163301 | ||
| Persistent expression of MNF identifies myogenic stem cells in postnatal muscles. | Q52192982 | ||
| Representation is faithfully preserved in global cDNA amplified exponentially from sub-picogram quantities of mRNA. | Q52941967 | ||
| Dystrophin expression in the mdx mouse restored by stem cell transplantation | Q59069004 | ||
| Mice without myoglobin | Q59075071 | ||
| EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells | Q74211173 | ||
| Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts | Q74397713 | ||
| Chimerism of the transplanted heart | Q77452324 | ||
| Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts | Q77885470 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 14 | |
| P304 | page(s) | 262-275 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Developmental Biology | Q3025402 |
| P1476 | title | Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart | |
| P478 | volume | 265 |
| Q37483053 | A heart full of stem cells: the spectrum of myocardial progenitor cells in the postnatal heart |
| Q36274962 | A novel two-step procedure to expand cardiac Sca-1+ cells clonally. |
| Q54608982 | ABC transporter expression profiling after ischemic reperfusion injury in mouse kidney. |
| Q37395423 | ABC transporters, drug resistance, and cancer stem cells |
| Q31138107 | ABCG2 transporter identifies a population of clonogenic human limbal epithelial cells. |
| Q54104981 | ATP Binding Cassette Sub-family Member 2 (ABCG2) and Xenobiotic Exposure During Early Mouse Embryonic Stem Cell Differentiation. |
| Q33764603 | ATP-binding cassette transporter Abcg2 lineage contributes to the cardiac vasculature after oxidative stress |
| Q34089050 | Abcg2 expression marks tissue-specific stem cells in multiple organs in a mouse progeny tracking model |
| Q35276797 | Abcg2 labels multiple cell types in skeletal muscle and participates in muscle regeneration |
| Q36549248 | Abcg2-Labeled Cells Contribute to Different Cell Populations in the Embryonic and Adult Heart |
| Q89888187 | Abcg2-expressing side population cells contribute to cardiomyocyte renewal through fusion |
| Q36789008 | Acute myocardial infarction induced functional cardiomyocytes to re-enter the cell cycle |
| Q64264854 | Adult Cardiac Stem Cell Aging: A Reversible Stochastic Phenomenon? |
| Q47097822 | Adult cardiac stem cells are multipotent and robustly myogenic: c-kit expression is necessary but not sufficient for their identification |
| Q36815983 | Adult stem cells and heart regeneration |
| Q37815089 | Adult stem cells: from new cell sources to changes in methodology |
| Q35565809 | An emerging consensus on cardiac regeneration |
| Q39654767 | Antitumor activity of satraplatin in cisplatin‐resistant oral squamous cell carcinoma cells |
| Q39514108 | At a crossroad: cell therapy for cardiac repair |
| Q37837891 | Autologous cell therapy for cardiac repair. |
| Q42912844 | B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cells |
| Q47270959 | Bioengineered Cardiac Tissue Based on Human Stem Cells for Clinical Application |
| Q38519839 | Biomaterial Approaches for Stem Cell-Based Myocardial Tissue Engineering |
| Q34304413 | Blood vessel repair and regeneration in the ischaemic heart |
| Q37293770 | Bone marrow-derived cells can acquire cardiac stem cells properties in damaged heart |
| Q41880515 | Bone-marrow-derived side population cells for myocardial regeneration |
| Q37958162 | Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression. |
| Q53823555 | Calcium-dependent potassium channels control proliferation of cardiac progenitor cells and bone marrow-derived mesenchymal stem cells. |
| Q89433765 | Can We Engineer a Human Cardiac Patch for Therapy? |
| Q35038054 | Cancer stem cells and side population cells in breast cancer and metastasis. |
| Q36206492 | Cardiac Bmi1(+) cells contribute to myocardial renewal in the murine adult heart |
| Q42718220 | Cardiac Progenitor Cells and the Interplay with Their Microenvironment |
| Q91643965 | Cardiac Progenitor Cells from Stem Cells: Learning from Genetics and Biomaterials |
| Q55085484 | Cardiac Progenitor Cells in Basic Biology and Regenerative Medicine. |
| Q90632565 | Cardiac Sca-1+ Cells Are Not Intrinsic Stem Cells for Myocardial Development, Renewal, and Repair |
| Q37800141 | Cardiac cell therapies: the next generation |
| Q34588417 | Cardiac muscle regeneration: lessons from development |
| Q36788885 | Cardiac myocyte cell cycle control in development, disease, and regeneration |
| Q34454071 | Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart |
| Q26739750 | Cardiac progenitor cells for heart repair |
| Q37767677 | Cardiac progenitor cells: potency and control |
| Q43145194 | Cardiac progenitor cells: the revolution continues |
| Q38079141 | Cardiac progenitor/stem cells on myocardial infarction or ischemic heart disease: what we have known from current research |
| Q35928368 | Cardiac regeneration |
| Q38336874 | Cardiac regeneration in children |
| Q38164335 | Cardiac regeneration: current therapies-future concepts |
| Q37253735 | Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease |
| Q36349185 | Cardiac repair by embryonic stem-derived cells |
| Q45839833 | Cardiac resident progenitor cells: evidence and functional significance |
| Q33270812 | Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo |
| Q26862552 | Cardiac side population cells: moving toward the center stage in cardiac regeneration |
| Q36267790 | Cardiac stem cells and mechanisms of myocardial regeneration |
| Q37206379 | Cardiac stem cells and myocardial disease |
| Q38030877 | Cardiac stem cells in patients with ischemic cardiomyopathy: discovery, translation, and clinical investigation |
| Q36603788 | Cardiac stem cells: A promising treatment option for heart failure |
| Q26825051 | Cardiac stem cells: biology and clinical applications |
| Q79579848 | Cardiac stem cells: isolation, expansion and experimental use for myocardial regeneration |
| Q39310120 | Cardiac stem cells: translation to human studies. |
| Q27025973 | Cardiac-derived stem cell-based therapy for heart failure: progress and clinical applications |
| Q37766199 | Cardiogenesis: an embryological perspective. |
| Q37319214 | Cardiogenic differentiation and transdifferentiation of progenitor cells |
| Q27009251 | Cardiomyocyte proliferation vs progenitor cells in myocardial regeneration: The debate continues |
| Q38588589 | Cardiomyocyte regeneration |
| Q35798731 | Cardiomyogenesis in the developing heart is regulated by c-kit-positive cardiac stem cells |
| Q33887672 | Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts |
| Q37002682 | Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis |
| Q42028739 | Cardiovascular Stem Cells in Regenerative Medicine: Ready for Prime Time? |
| Q53508391 | Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials. |
| Q27001159 | Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions |
| Q37776514 | Cell therapy for heart failure: the need for a new therapeutic strategy |
| Q37206495 | Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells |
| Q36667275 | Cell-based approaches for cardiac repair |
| Q36176132 | Cell-based therapy for prevention and reversal of myocardial remodeling |
| Q46065832 | Cellular ELF signals as a possible tool in informative medicine |
| Q39233839 | Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP. |
| Q90613746 | Cellular Processing of the ABCG2 Transporter-Potential Effects on Gout and Drug Metabolism |
| Q35808738 | Challenges for heart disease stem cell therapy |
| Q54387184 | Characterisation and cardiac directed differentiation of canine adult cardiac stem cells. |
| Q35029291 | Characterisation of human limbal side population cells isolated using an optimised protocol from an immortalised epithelial cell line and primary limbal cultures |
| Q34920768 | Characterization of cell subpopulations expressing progenitor cell markers in porcine cardiac valves. |
| Q33525639 | Characterization of side population cells from laryngeal cancer cell lines |
| Q37045339 | Chemotherapy and cardiotoxicity |
| Q39670555 | Comparison of the Side Populations in Pretreatment and Postrelapse Neuroblastoma Cell Lines |
| Q27021931 | Concise review: heart regeneration and the role of cardiac stem cells |
| Q36406455 | Contemplating the bright future of stem cell therapy for cardiovascular disease |
| Q42836395 | Cortical bone-derived stem cells: a novel class of cells for myocardial protection |
| Q36722039 | Creation of a biological pacemaker by gene- or cell-based approaches |
| Q40442893 | Current status of myocardial regeneration and cell transplantation |
| Q37835598 | Developmental and regenerative biology of multipotent cardiovascular progenitor cells |
| Q28080127 | Developmental origin and lineage plasticity of endogenous cardiac stem cells |
| Q37474581 | Developmental origin of postnatal cardiomyogenic progenitor cells |
| Q61801807 | Differentiation of CD45‑/CD31+ lung side population cells into endothelial and smooth muscle cells in vitro |
| Q28271060 | Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applications |
| Q36853973 | Dissecting the molecular relationship among various cardiogenic progenitor cells |
| Q48697095 | Divergent cell cycle kinetics of midgestation ventricular cells entail a higher engraftment efficiency after cell transplantation |
| Q36918318 | Do stem cells in the heart truly differentiate into cardiomyocytes? |
| Q59133041 | Does cardiac development provide heart research with novel therapeutic approaches? |
| Q36814737 | Donor cell transplantation for myocardial disease: does it complement current pharmacological therapies? |
| Q33213451 | Embryonic lung side population cells are hematopoietic and vascular precursors |
| Q39624485 | Embryonic stem cell-derived cardiomyocytes harbor a subpopulation of niche-forming Sca-1+ progenitor cells |
| Q33927331 | Endogenous retinoic acid regulates cardiac progenitor differentiation. |
| Q42090077 | Endothelial cells contribute to generation of adult ventricular myocytes during cardiac homeostasis |
| Q44727895 | Enhanced maintenance of rat islets of Langerhans on laminin-coated electrospun nanofibrillar matrix in vitro |
| Q24321427 | Establishment of endoderm progenitors by SOX transcription factor expression in human embryonic stem cells |
| Q47438101 | Evolving cell-based therapies for heart failure patients |
| Q28073078 | Exploring pericyte and cardiac stem cell secretome unveils new tactics for drug discovery |
| Q30514418 | Fetal cells traffic to injured maternal myocardium and undergo cardiac differentiation. |
| Q35654315 | Forward Programming of Cardiac Stem Cells by Homogeneous Transduction with MYOCD plus TBX5 |
| Q36569726 | From cardiac repair to cardiac regeneration--ready to translate? |
| Q34935524 | From fish to amphibians to mammals: in search of novel strategies to optimize cardiac regeneration |
| Q27334619 | Functional cardiomyocytes derived from Isl1 cardiac progenitors via Bmp4 stimulation |
| Q36861543 | Functional impairment of human resident cardiac stem cells by the cardiotoxic antineoplastic agent trastuzumab |
| Q33220978 | Gene expression profiling and localization of Hoechst-effluxing CD45- and CD45+ cells in the embryonic mouse lung |
| Q37156670 | Genetic enhancement of stem cell engraftment, survival, and efficacy |
| Q36540656 | Getting to the heart of myocardial stem cells and cell therapy |
| Q42578340 | Glioma and glioblastoma - how much do we (not) know? |
| Q34699013 | Growth factor-induced mobilization of cardiac progenitor cells reduces the risk of arrhythmias, in a rat model of chronic myocardial infarction. |
| Q61865123 | Growth-factor-mediated cardiac stem cell activation in myocardial regeneration |
| Q38018889 | Harnessing the potential of adult cardiac stem cells: lessons from haematopoiesis, the embryo and the niche |
| Q33827450 | Head and neck cancer stem cells: the side population |
| Q57395528 | Heart failure and regenerative cardiology |
| Q34390677 | Heart regeneration: Past, present and future |
| Q34009778 | Heterogeneity in SDF-1 expression defines the vasculogenic potential of adult cardiac progenitor cells |
| Q93120633 | Heterogeneity of Adult Cardiac Stem Cells |
| Q34658631 | Hhex and Cer1 mediate the Sox17 pathway for cardiac mesoderm formation in embryonic stem cells |
| Q39596402 | Higher frequencies of BCRP+ cardiac resident cells in ischaemic human myocardium |
| Q37368287 | Human Breast Cancer Stem Cells Have Significantly Higher Rate of Clathrin-Independent and Caveolin-Independent Endocytosis than the Differentiated Breast Cancer Cells |
| Q34938752 | Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology. |
| Q36804578 | Human embryonic stem cell-derived cardiomyocytes: inducing strategies. |
| Q37372976 | Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression |
| Q34043019 | Identification and characterization of a novel multipotent sub-population of Sca-1⁺ cardiac progenitor cells for myocardial regeneration |
| Q39729834 | Improving cardiac regeneration after injury: are we a step closer? |
| Q33912811 | In vitro and in vivo proliferation, differentiation and migration of cardiac endothelial progenitor cells (SCA1+/CD31+ side-population cells). |
| Q38916204 | Innate heart regeneration: endogenous cellular sources and exogenous therapeutic amplification |
| Q53362103 | Innovation in basic science: stem cells and their role in the treatment of paediatric cardiac failure--opportunities and challenges. |
| Q34501242 | Intramyocardial transplantation of cardiac mesenchymal stem cells reduces myocarditis in a model of chronic Chagas disease cardiomyopathy |
| Q42659946 | Is biological repair of heart on the horizon? |
| Q34271019 | Ischemia-reperfusion injury and pregnancy initiate time-dependent and robust signs of up-regulation of cardiac progenitor cells |
| Q54343615 | Isolation and characterization of resident endogenous c-Kit+ cardiac stem cells from the adult mouse and rat heart. |
| Q36691627 | Isolation and expansion of resident cardiac progenitor cells. |
| Q33648100 | Isolation of Resident Cardiac Progenitor Cells by Hoechst 33342 Staining |
| Q35635149 | Isolation of cardiovascular precursor cells from the human fetal heart |
| Q26849792 | Kinase-independent mechanisms of resistance of leukemia stem cells to tyrosine kinase inhibitors |
| Q37778540 | Lessons for cardiac regeneration and repair through development |
| Q38102770 | Limbal side population cells: a future treatment for limbal stem cell deficiency |
| Q83367156 | Loss of heterozygosity of the tumor suppressor gene Tg737 in the side population cells of hepatocellular carcinomas is associated with poor prognosis |
| Q37506545 | Lost in translation: what is limiting cardiomyoplasty and can tissue engineering help? |
| Q44611861 | Low oxygen tension is critical for the culture of human mesenchymal stem cells with strong osteogenic potential from haemarthrosis fluid |
| Q33646895 | Mapping of BrdU label-retaining dental pulp cells in growing teeth and their regenerative capacity after injuries |
| Q53576712 | Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. |
| Q38066135 | Migration of resident cardiac stem cells in myocardial infarction |
| Q28652074 | Minimum information specification for in situ hybridization and immunohistochemistry experiments (MISFISHIE) |
| Q30831016 | Molecular and cellular characterization of ABCG2 in the prostate |
| Q88970178 | Molecular basis of functional myogenic specification of Bona Fide multipotent adult cardiac stem cells |
| Q37808269 | Molecular physiology of cardiac regeneration |
| Q36672258 | Molecular signatures define myogenic stem cell populations |
| Q30595510 | Mouse adipose tissue stromal cells give rise to skeletal and cardiomyogenic cell sub-populations. |
| Q63364496 | Multipotent Progenitor Cells in Regenerative Cardiovascular Medicine |
| Q42407370 | Multipotent stem cells in cardiac regenerative therapy |
| Q33220573 | Multipotent stem cells in human corneal stroma |
| Q28085334 | Multipotent stem cells of the heart-do they have therapeutic promise? |
| Q34057361 | Musashi1 expression cells derived from mouse embryonic stem cells can be enriched in side population isolated by fluorescence activated cell sorter |
| Q38045804 | Myocardial regeneration of the failing heart |
| Q36710761 | Myocyte death and renewal: modern concepts of cardiac cellular homeostasis. |
| Q80204151 | Neural stem cell properties of Müller glia in the mammalian retina: regulation by Notch and Wnt signaling |
| Q42278740 | Nkx2-5 represses Gata1 gene expression and modulates the cellular fate of cardiac progenitors during embryogenesis. |
| Q28305555 | Novel therapy for myocardial infarction: can HGF/Met be beneficial? |
| Q82683222 | One answer, many further questions |
| Q34688306 | Optimised protocols for the identification of the murine cardiac side population. |
| Q38017961 | Optimizing cardiac repair and regeneration through activation of the endogenous cardiac stem cell compartment |
| Q37766810 | Origin of cardiac progenitor cells in the developing and postnatal heart |
| Q36828639 | Origins and fates of cardiovascular progenitor cells |
| Q47837438 | Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering |
| Q37689872 | Oxytocin: Old Hormone, New Drug |
| Q35775407 | PDGFRα demarcates the cardiogenic clonogenic Sca1+ stem/progenitor cell in adult murine myocardium |
| Q38136924 | Patching the heart: cardiac repair from within and outside |
| Q37964983 | Perspectives of purinergic signaling in stem cell differentiation and tissue regeneration. |
| Q38333728 | Pluripotent stem cell derived cardiovascular progenitors--a developmental perspective |
| Q37016190 | Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure |
| Q28306800 | Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages |
| Q36523923 | Potential of stem-cell-based therapies for heart disease |
| Q58816086 | Pressure overload leads to an increase of cardiac resident stem cells |
| Q30604339 | Prion protein- and cardiac troponin T-marked interstitial cells from the adult myocardium spontaneously develop into beating cardiomyocytes. |
| Q37595834 | Progenitor cell therapy for heart disease |
| Q26823933 | Programming and reprogramming a human heart cell |
| Q36327823 | Progress and prospects: cell based regenerative therapy for cardiovascular disease. |
| Q32186200 | Proliferation, differentiation and migration of SCA1-/CD31- cardiac side population cells in vitro and in vivo |
| Q41214335 | Promises and pitfalls in cell replacement therapy for heart failure |
| Q33234180 | Prospective isolation of murine hematopoietic stem cells by expression of an Abcg2/GFP allele |
| Q42531479 | Pump to survive: novel cytoprotective strategies for cardiac progenitor cells |
| Q44920860 | Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes |
| Q45760553 | Recapitulation of developmental cardiogenesis governs the morphological and functional regeneration of adult newt hearts following injury |
| Q27687840 | Regenerating functional heart tissue for myocardial repair |
| Q22251075 | Regenerating the heart |
| Q45882958 | Regeneration of dystrophin-expressing myocytes in the mdx heart by skeletal muscle stem cells |
| Q36038854 | Regeneration of the heart |
| Q37043525 | Regenerative biology: a historical perspective and modern applications |
| Q38174769 | Regenerative therapy for cardiovascular disease |
| Q43655496 | Regional and global protective effects of tissue kallikrein gene delivery to the peri-infarct myocardium |
| Q34774709 | Regulation of Cardiac Cell Fate by microRNAs: Implications for Heart Regeneration. |
| Q36767598 | Regulation of cardiomyocyte differentiation of embryonic stem cells by extracellular signalling |
| Q36118952 | Regulation of myogenic progenitor proliferation in human fetal skeletal muscle by BMP4 and its antagonist Gremlin |
| Q39154442 | Regulation of the microenvironment for cardiac tissue engineering |
| Q37104058 | Repairing damaged myocardium: evaluating cells used for cardiac regeneration |
| Q37774067 | Resident cardiac progenitor cells: at the heart of regeneration. |
| Q36406477 | Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration. |
| Q36406482 | Resident progenitors and bone marrow stem cells in myocardial renewal and repair |
| Q37766134 | Review of stem cell-based therapy for the treatment of cardiovascular disease |
| Q91638361 | Role of c-Kit in Myocardial Regeneration and Aging |
| Q33809635 | Role of stem cells in cardiovascular biology |
| Q33369009 | Role of the ATP-binding cassette transporter Abcg2 in the phenotype and function of cardiac side population cells |
| Q36250753 | Role of the breast cancer resistance protein (ABCG2) in drug transport |
| Q33260644 | SP analysis may be used to identify cancer stem cell populations |
| Q38220004 | Sca-1+ cardiac progenitor cells and heart-making: a critical synopsis. |
| Q33867517 | Self-beating atypically shaped cardiomyocytes survive a long-term postnatal development while preserving the expression of fetal cardiac genes in mice |
| Q60913751 | Side Population: Its Use in the Study of Cellular Heterogeneity and as a Potential Enrichment Tool for Rare Cell Populations |
| Q33210921 | Side population cells isolated from different tissues share transcriptome signatures and express tissue-specific markers. |
| Q36902543 | Somatic stem cell transplantation for the failing heart |
| Q36426360 | Sources of cardiomyocytes for stem cell therapy: an update |
| Q28505857 | Sox17 is essential for the specification of cardiac mesoderm in embryonic stem cells |
| Q35125820 | Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora's Box. |
| Q27026285 | Stem cell mechanisms during left ventricular remodeling post-myocardial infarction: Repair and regeneration |
| Q38098219 | Stem cell stimulation of endogenous myocyte regeneration |
| Q37995019 | Stem cell therapy for cardiac disease |
| Q34129904 | Stem cell therapy for cardiac dysfunction |
| Q37544884 | Stem cell therapy for cardiac repair: benefits and barriers |
| Q26866170 | Stem cell therapy for chronic heart failure: an updated appraisal |
| Q39850212 | Stem cell therapy for ischemic heart disease |
| Q38761212 | Stem cell therapy for ischemic heart diseases |
| Q33348580 | Stem cell therapy: pieces of the puzzle |
| Q38050281 | Stem cell-based therapy for ischemic heart disease. |
| Q37766151 | Stem cells and cardiac repair: a critical analysis |
| Q38273056 | Stem cells for cardiac regeneration and possible roles of the transforming growth factor-β superfamily |
| Q36225214 | Stem cells for cardiomyocyte regeneration: state of the art. |
| Q37132137 | Stem cells for cardiovascular repair - the challenges of the aging heart |
| Q37261623 | Stem cells for heart cell therapies |
| Q37153062 | Stem cells in the heart: what's the buzz all about?--Part 1: preclinical considerations |
| Q51893212 | Stem cells in toxicology: fundamental biology and practical considerations. |
| Q39141844 | Stem cells: An overview with respect to cardiovascular and renal disease |
| Q37089732 | Stem-cell therapy for cardiac disease |
| Q37164041 | Stem-cell-based therapy and lessons from the heart |
| Q37255265 | Stemming heart failure with cardiac- or reprogrammed-stem cells |
| Q34372277 | Stimulation of endogenous cardioblasts by exogenous cell therapy after myocardial infarction |
| Q38207943 | Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics |
| Q89445415 | Surface functionalization of polyurethane scaffolds mimicking the myocardial microenvironment to support cardiac primitive cells |
| Q34523263 | Tackling the cancer stem cells - what challenges do they pose? |
| Q35558497 | Terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and host cells |
| Q40496170 | The EAPC EXPERT tool. |
| Q51321659 | The Efflux Transporter ABCG2 Maintains Prostate Stem Cells. |
| Q28067832 | The Role of Cardiac Side Population Cells in Cardiac Regeneration |
| Q51996724 | The adult human heart as a source for stem cells: repair strategies with embryonic-like progenitor cells. |
| Q36174197 | The bone marrow--cardiac axis of myocardial regeneration |
| Q53471198 | The effect of calcium phosphate composite scaffolds on the osteogenic differentiation of rabbit dental pulp stem cells. |
| Q57172124 | The face of epicardial and endocardial derived cells in zebrafish |
| Q84080482 | The hypoxic epicardial and subepicardial microenvironment |
| Q45203190 | The lectin of Dolichos biflorus agglutinin recognises glycan epitopes on the surface of a subset of cardiac progenitor cells |
| Q33214923 | The mammary gland "side population": a putative stem/progenitor cell marker? |
| Q37766123 | The paracrine effect: pivotal mechanism in cell-based cardiac repair |
| Q37325686 | The potential of stem cells in the treatment of cardiovascular diseases |
| Q35814433 | The temporal and spatial expression patterns of ABCG2 in the developing human heart |
| Q37209658 | The therapeutic potential of embryonic and adult stem cells for skeletal muscle regeneration |
| Q36909360 | Therapeutic potential of adult progenitor cells in cardiovascular disease |
| Q38013063 | Thymosin β4 and cardiac regeneration: are we missing a beat? |
| Q37887539 | Tissue engineering and cell-based therapy toward integrated strategy with artificial organs |
| Q33226984 | Transcriptional profiling of mammary gland side population cells |
| Q29617742 | Tumour stem cells and drug resistance |
| Q37580197 | Ultrastructural and immunocharacterization of undifferentiated myocardial cells in the developing mouse heart. |
| Q99610827 | Uncoupling protein 2-mediated metabolic adaptations define cardiac cell function in the heart during transition from young to old age |
| Q33991646 | Urotensin II inhibited the proliferation of cardiac side population cells in mice during pressure overload by JNK-LRP6 signalling |
| Q42514824 | Urothelial Carcinoma Stem Cells: Current Concepts, Controversies, and Methods. |
| Q37812214 | Wnt Signaling and Aging-Related Heart Disorders |
Search more.